Miotox, LLC

9 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Jul 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 14, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Patent	Title	Status	Expires	Confidence
US 12,364,740	Zonal and Targeted Methods and Uses for Treating a Post-Traumatic Stress Disorder In force Term ends Jul 24, 2030 · High confidence	In force	Term ends Jul 24, 2030	High confidence
US 12,533,400	Zonal and Targeted Methods and Uses for Treating a Chronic Post-Traumatic Headache Associated with a Post-Traumatic Stress Disorder In force Term ends Jul 24, 2030 · High confidence	In force	Term ends Jul 24, 2030	High confidence
US 8,420,106	Extramuscular Treatment of Traumatic-Induced Migraine Headache In force Term ends May 23, 2032 · High confidence	In force	Term ends May 23, 2032	High confidence
US 8,491,917	Treatment of Migraine Headache with Diffusion of Toxin in Non-Muscle Related Areas of the Head In force Term ends May 23, 2032 · High confidence	In force	Term ends May 23, 2032	High confidence
US 8,617,569	Treatment of Migraine Headache with Diffusion of Toxin in Non-Muscle Related Foraminal Sites In force Term ends May 23, 2032 · High confidence	In force	Term ends May 23, 2032	High confidence
US 8,722,060	Method of Treating Vertigo In force Term ends May 23, 2032 · High confidence	In force	Term ends May 23, 2032	High confidence
US 8,883,143	Treatment of Traumatic-Induced Migraine Headache In force Term ends May 23, 2032 · High confidence	In force	Term ends May 23, 2032	High confidence
US 10,201,497	Treatment of Migraine Headaches with Presynaptic Neurotoxin In force Term ends May 23, 2032 · Medium confidence	In force	Term ends May 23, 2032	Medium confidence
US 12,178,862	Zonal and Targeted Methods and Uses for Treating a Migraine Disorder In force Term ends Jun 3, 2041 · High confidence	In force	Term ends Jun 3, 2041	High confidence

Also on record, not counted in the 9: 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 no status recorded

List them